Header cover image

Healthcare Healthcare Sector

Results

2301

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2301 companies

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

VTL

AU$0.02

7D

0%

1Y

n/a

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

TGIF

CA$0.005

7D

0%

1Y

-66.7%

Diagnamed Holdings

Market Cap: CA$2.4m

Engages in the development and commercialization of AI healthcare solutions.

DMED

CA$0.045

7D

50.0%

1Y

50.0%

Appili Therapeutics

Market Cap: CA$2.4m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

APLI

CA$0.015

7D

0%

1Y

-62.5%

TNF Pharmaceuticals

Market Cap: US$1.7m

A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

TNFA

US$0.17

7D

1.7%

1Y

-91.6%

Lifeline Biotechnologies

Market Cap: US$1.7m

Operates as a medical technology company in the United States.

LLBO

US$0.0004

7D

100.0%

1Y

0%

OMID Holdings

Market Cap: US$1.7m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

OMID

US$0.018

7D

-10.0%

1Y

-40.0%

Catheter Precision

Market Cap: US$1.7m

Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.

VTAK

US$0.19

7D

-10.1%

1Y

-96.2%

Ayala Pharmaceuticals

Market Cap: US$1.7m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

ADXS

US$0.035

7D

-6.9%

1Y

-86.0%

LungLife AI

Market Cap: UK£1.3m

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

LLAI

UK£0.042

7D

18.6%

1Y

-78.2%

Medicine Man Technologies

Market Cap: US$1.7m

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

SHWZ

US$0.02

7D

0%

1Y

-95.6%

Salarius Pharmaceuticals

Market Cap: US$1.7m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

SLRX

US$0.79

7D

1.6%

1Y

-78.6%

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

PYC

UK£0.0042

7D

-1.2%

1Y

-68.1%

NewGenIvf Group

Market Cap: US$1.7m

An investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

NIVF

US$2.19

7D

-17.0%

1Y

-99.1%

City View Green Holdings

Market Cap: CA$2.3m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

CVGR

CA$0.005

7D

-50.0%

1Y

n/a

United American Healthcare

Market Cap: US$1.7m

Through its subsidiaries, provides contract manufacturing services to the medical device industry.

UAHC

US$0.014

7D

0%

1Y

-38.7%

Binovi Technologies

Market Cap: CA$2.3m

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

VISN.H

CA$0.085

7D

0%

1Y

n/a

Helix BioMedix

Market Cap: US$1.6m

Operates as a specialty dermatology and consumer products skin health company in the United States.

HXBM

US$7.18

7D

0%

1Y

n/a

Agentix

Market Cap: US$1.6m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

AGTX

US$0.04

7D

-20.0%

1Y

n/a

Processa Pharmaceuticals

Market Cap: US$1.6m

A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.

PCSA

US$0.30

7D

24.6%

1Y

-80.8%

Kaya Holdings

Market Cap: US$1.6m

A vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics, medical and recreational cannabis, and CBD products primarily in the United States.

KAYS

US$0.038

7D

-2.5%

1Y

-7.3%

Imagion Biosystems

Market Cap: AU$2.4m

Provides medical imaging technologies using magnetic resonance.

IBX

AU$0.012

7D

-7.7%

1Y

n/a

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

HMPG

CA$0.015

7D

0%

1Y

-72.7%

Careteq

Market Cap: AU$2.4m

A medication management services company for health, aged, and home care sectors worldwide.

CTQ

AU$0.01

7D

-23.1%

1Y

-23.1%

MyndTec

Market Cap: CA$2.1m

A medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States.

MYTC

CA$0.08

7D

0%

1Y

-89.3%

Meridian Holdings

Market Cap: US$1.5m

Through its subsidiaries, provides healthcare management and information system solutions in the United States.

MRDH

US$0.01

7D

0%

1Y

n/a

GelStat

Market Cap: US$1.5m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

GSAC

US$0.0004

7D

0%

1Y

0%

Bio-Path Holdings

Market Cap: US$1.5m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

BPTH

US$0.17

7D

-3.4%

1Y

-91.2%

SOHM

Market Cap: US$1.5m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

SHMN

US$0.0007

7D

0%

1Y

-36.4%

Medical Marijuana

Market Cap: US$1.5m

An investment holding company, operates in the cannabinoid-based nutraceutical industry.

MJNA

US$0.0003

7D

20.0%

1Y

-84.2%

Algernon Pharmaceuticals

Market Cap: CA$2.0m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

AGN

CA$0.08

7D

-11.1%

1Y

-48.4%

CBD of Denver

Market Cap: US$1.5m

Engages in developing and commercializing cannabidiol (CBD) products.

CBDD

US$0.0002

7D

0%

1Y

-71.4%

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

WIB

CA$0.13

7D

0%

1Y

4.0%

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

HEAL

CA$0.06

7D

0%

1Y

-70.0%

Procyon

Market Cap: US$1.5m

Manufactures and markets wound and skin care products primarily in the United States.

PCYN

US$0.000001

7D

n/a

1Y

-100.0%

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

ABTI

US$0.001

7D

0%

1Y

-95.0%

Page 48 of 64